Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
Therapie
|
July 1, 1996
Drug metabolism as a confounding factor in PK/PD population approaches
L P Balant, M Gex-Fabry, E Balant-Gorgia
Revue Medicale Suisse
|
October 21, 2009
[Current topics in pharmacokinetics and pharmacogenetics of antidepressant drugs]
M Gex-Fabry, G Bertschy, M Kosel, et al.
Psychopharmacology Series
|
January 1, 1989
Detection of populations at risk using drug monitoring data
A E Balant-Gorgia, M Gex-Fabry, L P Balant
European Journal of Clinical Pharmacology
|
April 7, 1999
Clomipramine concentration as a predictor of delayed response: a naturalistic study
M Gex-Fabry, A E Balant-Gorgia, L P Balant
Bollettino Chimico Farmaceutico
|
October 1, 1994
[Biopharmaceutics and pharmacokinetics. 10. Integration of the two concepts: A. Monocompartmental models]
L P Balant, N Brega, M Gex-Fabry, et al.
Drug Safety
|
December 12, 2001
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions
M Gex-Fabry, A E Balant-Gorgia, L P Balant
Psychopharmacology Series
|
January 1, 1993
Analysis of 935 haloperidol concentration measurements obtained during routine drug monitoring of 134 patients
M Gex-Fabry, A E Balant-Gorgia, L P Balant
Schweizer Archiv Fur Neurologie Und Psychiatrie (Zurich, Switzerland : 1985)
|
January 1, 1989
[Epidemiology of psychotropic drugs: possibilities and limits of studies on therapeutic monitoring]
L P Balant, A E Balant-Gorgia, M Gex-Fabry
Therapie
|
July 1, 1996
Therapeutic drug monitoring and drug-drug interactions: a pharmacoepidemiological perspective
A E Balant-Gorgia, M Gex-Fabry, L P Balant
Clinical Therapeutics
|
May 1, 1992
Milestones in clinical pharmacology. From experimental to clinical pharmacokinetics
L P Balant, M Gex-Fabry, A E Balant-Gorgia
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
Therapie
|
July 1, 1996
Drug metabolism as a confounding factor in PK/PD population approaches
L P Balant, M Gex-Fabry, E Balant-Gorgia
Revue Medicale Suisse
|
October 21, 2009
[Current topics in pharmacokinetics and pharmacogenetics of antidepressant drugs]
M Gex-Fabry, G Bertschy, M Kosel, et al.
Psychopharmacology Series
|
January 1, 1989
Detection of populations at risk using drug monitoring data
A E Balant-Gorgia, M Gex-Fabry, L P Balant
European Journal of Clinical Pharmacology
|
April 7, 1999
Clomipramine concentration as a predictor of delayed response: a naturalistic study
M Gex-Fabry, A E Balant-Gorgia, L P Balant
Bollettino Chimico Farmaceutico
|
October 1, 1994
[Biopharmaceutics and pharmacokinetics. 10. Integration of the two concepts: A. Monocompartmental models]
L P Balant, N Brega, M Gex-Fabry, et al.
Drug Safety
|
December 12, 2001
Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions
M Gex-Fabry, A E Balant-Gorgia, L P Balant
Psychopharmacology Series
|
January 1, 1993
Analysis of 935 haloperidol concentration measurements obtained during routine drug monitoring of 134 patients
M Gex-Fabry, A E Balant-Gorgia, L P Balant
Schweizer Archiv Fur Neurologie Und Psychiatrie (Zurich, Switzerland : 1985)
|
January 1, 1989
[Epidemiology of psychotropic drugs: possibilities and limits of studies on therapeutic monitoring]
L P Balant, A E Balant-Gorgia, M Gex-Fabry
Therapie
|
July 1, 1996
Therapeutic drug monitoring and drug-drug interactions: a pharmacoepidemiological perspective
A E Balant-Gorgia, M Gex-Fabry, L P Balant
Clinical Therapeutics
|
May 1, 1992
Milestones in clinical pharmacology. From experimental to clinical pharmacokinetics
L P Balant, M Gex-Fabry, A E Balant-Gorgia
Page
of 6